Quantinuum Inc. (QNT) extended its rally Wednesday, with shares climbing to $81.01 in premarket trading following a 13.46% surge on Tuesday. The stock closed at $77.46 Tuesday, driven by a White House directive for a national quantum computing initiative and a strategic collaboration with Hewlett Packard Enterprise (HPE).
White House Quantum Directive
On June 22, the White House ordered a new national effort to advance quantum computers and post-quantum cryptography, aiming to boost scientific research and federal encryption against quantum attacks. Michael Kratsios, director of the White House Office of Science and Technology Policy, told Reuters, "We believe this can happen by 2028." This policy signal reignited investor interest in quantum stocks, with Quantinuum leading the charge.
HPE Collaboration
Quantinuum announced a partnership with Hewlett Packard Enterprise to integrate quantum computing with high-performance computing (HPC) and AI systems. CEO Rajeeb Hazra emphasized the goal of making quantum machines work alongside classical computers, delivering "practical, real-world value" for industrial clients. HPE, however, is pursuing a multi-vendor strategy, working with Intel, IQM, Quantinuum, QuEra, Rigetti, and others. HPE exec Trish Damkroger stated the plan is to make quantum "accessible, scalable and operational."
Valuation Concerns
Despite the rally, Quantinuum's valuation remains extreme. With a market capitalization of approximately $21.2 billion based on the premarket bid and trailing revenue of just $17.08 million, the price-to-sales ratio stands at roughly 1,240. This compares to IonQ at about 115x sales, D-Wave at 745x, and Rigetti at 706x. The company also reported a trailing 12-month net loss of $298.67 million.
Market Context
Quantinuum, which went public at $60 per share, is now trading 35% above its IPO price. The company raised $1.68 billion by selling 28 million shares in an upsized offering. While the White House push and HPE deal provide near-term catalysts, the stock's lofty multiple leaves little room for error. Any delays in federal quantum targets or failure of HPE pilots to convert could trigger sharp multiple compression.
Risks Ahead
The quantum sector remains speculative, with most companies far from profitability. Quantinuum's revenue base is minuscule relative to its market cap, and the stock prices in a rapid transition from research to commercial adoption. If rivals like IonQ, D-Wave, and Rigetti capture a larger share of early government and enterprise spending, QNT's sales multiple could contract faster than its revenue can grow. Investors should weigh these risks against the policy tailwinds.
